Drug Trial Radar · NCT06254950
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
213
Actual
Start
Mar 29, 2024
Primary completion
Jul 14, 2026
Study completion Aug 4, 2027
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Feb 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Conditions
- Ulcerative Colitis
Interventions
TAK-279Drug
TAK-279 capsules.
PlaceboDrug
TAK-279 placebo-matching capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Clinical Remission at Week 12 Based on Modified Mayo Score (mMS)Time frame: Week 12
Locations
141 sites in 22 countries. Site status is shown where the registry gives one.
GastroIntestinal BioSciences
Los Angeles, California
United Medical Doctors
Murrieta, California
West Central Gastroenterology, LLP, d/b/a/ Gastro Florida
Clearwater, Florida
Auzmer Research
Lakeland, Florida
GI PROS, Inc.
Naples, Florida
USF Health Morsani Center for Advanced Healthcare
Tampa, Florida
Emory University Hospital, The Emory Clinic
Atlanta, Georgia
Atlanta Center For Gastroenterology, P.C.
Decatur, Georgia
University Of Louisville
Louisville, Kentucky
Woodholme Gastroenterology Associates
Glen Burnie, Maryland
Las Vegas Medical Research
Las Vegas, Nevada
University Gastroenterology
Providence, Rhode Island
Gastroenterology Associates, PA
Greenville, South Carolina
Novel Research, LLC
Bellaire, Texas
Tyler Research Institute, LLC
Tyler, Texas
University of Washington Medical Center
Seattle, Washington
Harry Perkins Medical Research Institute Fiona Stanley Hospital
Murdoch, Australia
Concord Repatriation General Hospital
Sydney, New South Wales, Australia
Mater Cancer Care Centre-Mater Health Services
South Brisbane, Queensland, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
The Queen Elizabeth Hospital
Woodville, South Australia, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Western Health/Footscray Hospital
Melbourne, Victoria, Australia
Sir Charles Gairdner Hospital Lung Institute Of Western Australia
Nedlands, Western Australia, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Universitair Ziekenhuis Leuven
Leuven, Belgium
Hopital Universitaire de Bruxelles/ Academisch Ziekenhuis Burssel
Brussels, Anderlecht / Region Capitale de Bruxelles/ Brussel, Belgium
UMBAL Kaspela
Plovdiv, Bulgaria
Pecs University Clinical Center Mohacs Hospital
Sofia, Bulgaria
Acibadem City clinic Tokuda hospital
Sofia, Bulgaria
Diagnostic-Consultative Center Aleksandrovska EOOD
Sofia, Bulgaria
University Hospital Tsaritsa Yoanna - Isul (University Hospital Queen Giovanna)
Sofia, Bulgaria
University Hospital City Clinic Cancer Center
Sofia, Bulgaria
Heritage Medical Research Clinic - University Of Calgary
Calgary, Alberta, Canada
Fraser Clinical Trials
New Westminster, British Columbia, Canada
London Health Sciences Centre - University Hospital
London, Ontario, Canada
London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada
The Research Institute of the McGill University Health Center
Montreal, Quebec, Canada
Zhejiang University School of Medicine - Sir Run Run Shaw Hospital (SRRSH)
Hangzhou, China
Showing 40 of 141 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.